Indian Pharma Products
- All
- News
- Videos
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
Focus On Another India Pharma Firm After WHO Alert Over Contaminated Syrup
The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in serious injury or death.
-
Indian Firm Suspends Production Of Eye Drops Linked To Death In US
The US Centers for Disease Control and Prevention (CDC) said it is testing unopened bottles of EzriCare Artificial Tears eye drops, manufactured by Chennai-based Global Pharma Healthcare.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
Sensex Crashes Over 1,800 Points In 3 Days; Nifty Barely Holds 17,750: 10 Points
The Indian equity benchmarks on Thursday extended fall to the third straight session due to selling pressure in information technology, consumer products and pharma stocks. The 30-share BSE Sensex slumped 634 points or 1.06 per cent to close at 59,465, while the broader NSE Nifty settled 181 points or 1.01 per cent lower at 17,757. In late deals, t...
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Wockhardt Makes Deal For Mystery Vaccine, Announcement In 2 Weeks
Indian pharma major Wockhardt is set to announce a major production deal for an undisclosed vaccine. The formal announcement is due in two weeks and the production of the vaccine will begin in October.
-
Indian Pharma Firms Go Local Seeking To End Reliance On China
Indian Pharma Firms: Although India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019 from nearly nothing three decades ago
-
Volume Decline Muted Pharmaceutical Market Growth In November
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
Nifty Futures Indicate Flat Start For Indian Markets; Sun Pharma In Focus
Sun Pharma will be in focus today as it signed an agreement with China Medical System Holdings for generic products sale in Mainland China.
-
Lupin Profit Falls 43% In June Quarter, Misses Analysts' Estimate
Sanctions imposed by international regulatory bodies and warnings over quality control at production sites have hurt sales in the United States where Indian pharmaceutical firms accounted for a third of the drugs sold.
-
Sun Pharma Bets On New Products To Boost US Skincare Products Growth
India's largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative U.S. dermatology business, its U.S. chief said.
-
USFDA Rejected 12,012 Products Since January 2011: Nirmala Sitharaman
The US health regulator has refused entry of 12,012 Indian products, including drugs, into the American market between January 2011 and March 2016 for various reasons, including adulteration and misbranding, Parliament was informed on Monday.
-
Medical Devices Get Voluntary Certification Scheme
A voluntary certification scheme for medical devices was on Tuesday rolled out in a bid to address lack of quality assurance for products manufactured in the country.
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
Focus On Another India Pharma Firm After WHO Alert Over Contaminated Syrup
The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in serious injury or death.
-
Indian Firm Suspends Production Of Eye Drops Linked To Death In US
The US Centers for Disease Control and Prevention (CDC) said it is testing unopened bottles of EzriCare Artificial Tears eye drops, manufactured by Chennai-based Global Pharma Healthcare.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
Sensex Crashes Over 1,800 Points In 3 Days; Nifty Barely Holds 17,750: 10 Points
The Indian equity benchmarks on Thursday extended fall to the third straight session due to selling pressure in information technology, consumer products and pharma stocks. The 30-share BSE Sensex slumped 634 points or 1.06 per cent to close at 59,465, while the broader NSE Nifty settled 181 points or 1.01 per cent lower at 17,757. In late deals, t...
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Wockhardt Makes Deal For Mystery Vaccine, Announcement In 2 Weeks
Indian pharma major Wockhardt is set to announce a major production deal for an undisclosed vaccine. The formal announcement is due in two weeks and the production of the vaccine will begin in October.
-
Indian Pharma Firms Go Local Seeking To End Reliance On China
Indian Pharma Firms: Although India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019 from nearly nothing three decades ago
-
Volume Decline Muted Pharmaceutical Market Growth In November
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
Nifty Futures Indicate Flat Start For Indian Markets; Sun Pharma In Focus
Sun Pharma will be in focus today as it signed an agreement with China Medical System Holdings for generic products sale in Mainland China.
-
Lupin Profit Falls 43% In June Quarter, Misses Analysts' Estimate
Sanctions imposed by international regulatory bodies and warnings over quality control at production sites have hurt sales in the United States where Indian pharmaceutical firms accounted for a third of the drugs sold.
-
Sun Pharma Bets On New Products To Boost US Skincare Products Growth
India's largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative U.S. dermatology business, its U.S. chief said.
-
USFDA Rejected 12,012 Products Since January 2011: Nirmala Sitharaman
The US health regulator has refused entry of 12,012 Indian products, including drugs, into the American market between January 2011 and March 2016 for various reasons, including adulteration and misbranding, Parliament was informed on Monday.
-
Medical Devices Get Voluntary Certification Scheme
A voluntary certification scheme for medical devices was on Tuesday rolled out in a bid to address lack of quality assurance for products manufactured in the country.
